V. Strand

发表论文 676 篇 · 总被引 34369 次 · h-index 93

代表论文

• Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3) (2023 · Annals of the Rheumatic Diseases · 被引 37)
• Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2) (2023 · Annals of the Rheumatic Diseases · 被引 36)
• The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial. (2023 · The Lancet Rheumatology · 被引 30)
• The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout (2023 · Rheumatology · 被引 21)
• Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension (2023 · RMD Open · 被引 21)
• 25 years of biologic DMARDs in rheumatology (2023 · Nature Reviews Rheumatology · 被引 20)